Ruxolitinib cream for the treatment of vitiligo - Authors' reply

Lancet. 2020 Nov 28;396(10264):1736. doi: 10.1016/S0140-6736(20)32470-3.

Authors

David Rosmarin¹, Kathleen Butler², Fiona Kuo², John E Harris³

Affiliations

¹ Tufts Medical Center, Boston, MA 02111, USA. Electronic address: drosmarin@tuftsmedicalcenter.org.
² Incyte Corporation, Wilmington, DE, USA.
³ University of Massachusetts Medical School, Worcester, MA, USA.

PMID: 33248494
DOI: 10.1016/S0140-6736(20)32470-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Nitriles
Ointments
Pyrazoles
Pyrimidines
Vitiligo* / drug therapy

Substances

Nitriles
Ointments
Pyrazoles
Pyrimidines
ruxolitinib